Navigation Links
Duane Reade Holdings, Inc. Further Strengthens Management Team With Addition of Frank Scorpiniti, SVP, Pharmacy Operations
Date:12/8/2008

NEW YORK, Dec. 8 /PRNewswire/ -- Duane Reade Holdings, Inc. today announced the appointment of Mr. Frank Scorpiniti, 38, as Senior Vice President of Pharmacy Operations effective December 1, 2008. Mr. Scorpiniti reports directly to John Lederer, Chairman and Chief Executive Officer. His appointment adds value and expertise to Duane Reade's capable management team which has recently benefited from the appointments of several other senior executives.

Mr. John Lederer, Chairman and Chief Executive Officer, commented, "We are very pleased to have Frank Scorpiniti join our strong management team as Senior Vice President of Pharmacy Operations. We are confident that Frank's many years of experience in the pharmacy industry and his strong track record in raising customer service standards will help us to significantly improve our pharmacy business and increase the accessibility and availability of our pharmacy offerings."

Mr. Scorpiniti, a 13-year veteran of the pharmacy industry, comes to Duane Reade from Longs Drug Store Corporation, a West Coast regional pharmacy chain store that recently became a wholly-owned subsidiary of CVS Caremark Corporation. Mr. Scorpiniti held positions of increasing responsibility throughout his career at Longs and most recently served as Vice President of Pharmacy Operations, overseeing all aspects of Longs' pharmacy business.

Mr. Scorpiniti received his doctorate of pharmacy from University of the Pacific in Stockton, California.

About Duane Reade

Founded in 1960, Duane Reade is the largest drug store chain in the metropolitan New York City area, offering a wide variety of prescription and over-the-counter drugs, health and beauty care items, cosmetics, greeting cards, photo supplies and photofinishing. As of September 27, 2008, the Company operated 245 stores.

Except for historical information contained herein, the statements in this release and the accompanying discussion on the earnings conference call are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition, this document may contain statements, estimates or projections that constitute "forward-looking" statements as defined under U.S. federal securities laws. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ materially from forecasted or expected results. Those risks include, among other things, the competitive environment in the drug store industry in general and in the New York metropolitan area, the ability to open and operate new stores, the continued efforts by payers and government agencies to reduce prescription reimbursement rates and prescription drug benefits,

the strength of the economy in general, the economic conditions in the New York greater metropolitan area, changes in federal and state laws and regulations, including the potential impact of changes in regulations surrounding the importation of pharmaceuticals from foreign countries and changes in laws governing minimum wage requirements, changes in the Company's operating strategy, capital expenditure plans or development plans, the Company's ability to attract, hire and retain qualified pharmacy and other personnel, the Company's significant indebtedness, labor disturbances, the continued impact of, or new occurrences of, terrorist attacks in the New York greater metropolitan area and any actions that may be taken in response, demographic changes, the Company's ability to limit fraud and shrink, the

results of the Company's legal proceedings and recalls of pharmaceutical products due to health concerns or other reasons. Those and other risks are more fully described in Duane Reade's reports filed with the SEC from time to time, including its annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.

     Contact:   Duane Reade Holdings, Inc.
                John Henry
                Chief Financial Officer
                (212) 273-5746

    Investors:  Cara O'Brien/Caren Villarreal
    Press:      Diane Zappas
                (212) 850-5600
                FD


'/>"/>
SOURCE Duane Reade Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Duane Reade Holdings, Inc. Reports Third Quarter Results
2. Duane Reade Goes Pink to Support 2008 Komen New York City Race for the Cure(R)
3. Duane Reade Announces Proud Sponsorship of AIDS Walk New York
4. Duane Reade Holdings, Inc. Announces Resignation of Chief Marketing Officer
5. Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results
6. Duane Reade Holdings, Inc. to Report Third Quarter 2007 Financial Results
7. Gerstman Family Spotlighted on Readers Digest Website
8. Health Book Summaries Subscriber Base Grows to 60,000 Readers as Health Consumers Applaud Free Format
9. Misys Wins Best Trade Processing Product Accolade in European Banking Technology Readers Choice Awards
10. Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Readers Digest for Exemplifying the Fight Against Breast Cancer
11. Superfast Lightweight Free PDF Reader is Launched by Drumlin Security
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Texas Physical Therapy ... be found at 9618 Huebner Road. The clinic is the group’s 7th location in ... and Dr. Ali Higgins, PT, will provide care from the clinic, which opened March ...
(Date:3/24/2017)... ... March 24, 2017 , ... In just two days, ... vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 milestone so quickly,10-times ... 2,000 consumers (and counting) already backing the campaign. , “We are very ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of Enea, Scanlan & ... announce Westchester resident Lauren C. Enea has joined the firm as an associate attorney. ... her practice in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. ...
(Date:3/24/2017)... ... 24, 2017 , ... Judy Buchanan, co-owner of Serenity Natural ... Judy says, “I am passionate about sharing Reiki as a holistic, complementary therapy ... challenging time.” , A Certified Medical Reiki™ Master trained by Raven Keys Medical ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... collection of inspiring stories about real people of God in congregations across the ... John Miller, a Presbyterian minister ordained in 1964 who has served congregations in ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... The key factors driving the growth of dialysis ... growth and increasing healthcare expenditure. Some of the noteworthy trends ... ESRD patients, rising demand for home PD treatment and huge ... market is hindered by high treatment costs and stringent regulations. ... Complete ...
(Date:3/23/2017)... -- Executive Summary ... research (inputs from industry experts, companies, stakeholders) and ... analysis of global heart valve devices market on ... Procedure By Technique (Mechanical, Bioprosthetic, Transcatheter Aortic Valve ... Valvuloplasty, Transcatheter Mitral Valve Repair (TMVR)), By Region ...
(Date:3/23/2017)... , March 23, 2017  The U.S. Food ... (avelumab) for the treatment of adults and pediatric patients ... (MCC), including those who have not received prior chemotherapy. ... a rare, aggressive form of skin cancer. ... cancers, patients with a rare form called Merkel cell ...
Breaking Medicine Technology: